Investing in Radiology Clinician-Scientists
Supporting radiology clinician-scientists is essential for innovation — a strategic investment that can transform patient care and the future of academic medicine.
Read moreThe American College of Radiology® (ACR®) Committee on Drugs and Contrast Media this week released a revised contrast statement that provides flexibility to facilities for contrast studies while maintaining patient safety.
If a physician provides direct supervision for the study — on-site or remotely — the revised statement makes clear a medical professional trained to manage contrast reactions should be on-site.
Healthcare providers with the capabilities specified in the contrast statement can provide the service on-site, as long as those qualifications and the process are consistent with state and local laws and policies, as well as the process and policies of the service site.
Investing in Radiology Clinician-Scientists
Supporting radiology clinician-scientists is essential for innovation — a strategic investment that can transform patient care and the future of academic medicine.
Read moreCollaborating to Crush Cancer
Communities Crushing Cancer empowers residents and trainees to lead cancer screening awareness initiatives, foster collaboration, and expand outreach nationwide.
Read moreACR Highlights Imaging Payment Changes in HOPPS Final Rule
ACR outlines key radiology updates in CMS 2026 HOPPS final rule, including payment changes and quality reporting updates effective Jan. 1.
Read more